<code id='046679570B'></code><style id='046679570B'></style>
    • <acronym id='046679570B'></acronym>
      <center id='046679570B'><center id='046679570B'><tfoot id='046679570B'></tfoot></center><abbr id='046679570B'><dir id='046679570B'><tfoot id='046679570B'></tfoot><noframes id='046679570B'>

    • <optgroup id='046679570B'><strike id='046679570B'><sup id='046679570B'></sup></strike><code id='046679570B'></code></optgroup>
        1. <b id='046679570B'><label id='046679570B'><select id='046679570B'><dt id='046679570B'><span id='046679570B'></span></dt></select></label></b><u id='046679570B'></u>
          <i id='046679570B'><strike id='046679570B'><tt id='046679570B'><pre id='046679570B'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:68
          Micky Tripathi Office of the National Coordinator for Health Information Technology

          Micky Tripathi is equal parts excited — and deeply concerned — about the technological change sweeping through medicine.

          As adoption of generative AI races ahead,  his job as National Coordinator for Health Information Technology under President Joe Biden is to manage this change, and keep it safe and organized. But how do you organize a pell-mell rush? How do you keep chaos safe?

          advertisement

          “It’s definitely changed my life,” Tripathi said of his official remit, which also led to his appointment as co-chair of a task force on AI within the Department of Health and Human Services.  “We believe it’s really, really important that we be out ahead of this.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

          Advancesingenetherapycouldeventually"cure"manyformsofcongenitaldeafness.Thechangeshavemanydeafpeople

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Insmed lung disease drug hits target in key Phase 3 trial

          AdobeAnexperimentaldrugfromInsmedIncorporatedsuccessfullyreducedlungproblemsamongpatientswithanairwa